Prelude Capital Management’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
VCM
SLG
VPM
PTC
PGCM
Prelude Capital Management's GDRX Position: Q1 2026 in Review
Prelude Capital Management sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 22,100 shares — an estimated $59.9K sold.
Prelude Capital Management first reported a position in GDRX in Q2 2022 and held it in 11 quarters. The position peaked at $406K in Q4 2023. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.
- Prelude Capital Management reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
- Prelude Capital Management sold 22,100 GoodRx Holdings shares in Q1 2026, an estimated $59.9K.
- Prelude Capital Management first reported a position in GoodRx Holdings in Q2 2022 and held it in 11 quarters.
- Prelude Capital Management's GoodRx Holdings position peaked at $406K in Q4 2023.
- 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.